Plasma mediators in patients with severe COVID-19 cause lung endothelial barrier failure
Laura Michalick, Sarah Weidenfeld, Benjamin Grimmer, Diana Fatykhova, Philip Daniel Solymosi, Felix Behrens, Melanie Dohmen, Markus C. Brack, Sabrina Schulz, Elisa Thomasch, Szandor Simmons, Holger Müller-Redetzky, Norbert Suttorp, Florian Kurth, Jens Neudecker, Mario Toennies, Torsten T. Bauer, Stephan Eggeling, Victor Max Corman, Andreas C. Hocke, Martin Witzenrath, Stefan Hippenstiel, Wolfgang M. Kuebler
Source: Eur Respir J, 57 (3) 2002384; 10.1183/13993003.02384-2020
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Laura Michalick, Sarah Weidenfeld, Benjamin Grimmer, Diana Fatykhova, Philip Daniel Solymosi, Felix Behrens, Melanie Dohmen, Markus C. Brack, Sabrina Schulz, Elisa Thomasch, Szandor Simmons, Holger Müller-Redetzky, Norbert Suttorp, Florian Kurth, Jens Neudecker, Mario Toennies, Torsten T. Bauer, Stephan Eggeling, Victor Max Corman, Andreas C. Hocke, Martin Witzenrath, Stefan Hippenstiel, Wolfgang M. Kuebler. Plasma mediators in patients with severe COVID-19 cause lung endothelial barrier failure. Eur Respir J, 57 (3) 2002384; 10.1183/13993003.02384-2020
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: